Prenetics Global (Prenetics Global) Net Reserve Development From Prior Years (USD Mil) : 0.00 (As of Jun. 2019)

View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Net Reserve Development From Prior Years (USD Mil)?

Net Reserve Development From Prior Years (USD Mil) is the difference between the final losses recorded by an insurer and what the insurer originally recorded.

The historical rank and industry rank for Prenetics Global's Net Reserve Development From Prior Years (USD Mil) or its related term are showing as below:

PRE's Net Reserve Development From Prior Years (USD Mil) is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median:
* Ranked among companies with meaningful Net Reserve Development From Prior Years (USD Mil) only.

Prenetics Global Net Reserve Development From Prior Years (USD Mil) Historical Data

The historical data trend for Prenetics Global's Net Reserve Development From Prior Years (USD Mil) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Net Reserve Development From Prior Years (USD Mil) Chart

Prenetics GlobalQuarterly Data

Trend

Jun17

Sep17

Mar18

Jun18

Jun19

Net Reserve Development From Prior Years (USD Mil)

Get a 7-Day Free Trial

Competitive Comparison of Prenetics Global's Net Reserve Development From Prior Years (USD Mil)

For the Diagnostics & Research subindustry, Prenetics Global's Net Reserve Development From Prior Years (USD Mil), along with its competitors' market caps and Net Reserve Development From Prior Years (USD Mil) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prenetics Global (NAS:PRE) Net Reserve Development From Prior Years (USD Mil) Explanation

Net Reserve Development From Prior Years (USD Mil) is the difference between the final losses recorded by an insurer and what the insurer originally recorded. Prior years’ loss reserve development is useful to the company's management team, as it allows them to assess the impact of incurred claims from previous calendar years on current period earnings.

Generally, lower Prior Years’ Reserve Development is better because it means a higher accuracy on predicting the loss on incurred claims.

Prenetics Global Net Reserve Development From Prior Years (USD Mil) Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Net Reserve Development From Prior Years (USD Mil) provided by GuruFocus.com. Please click on the following links to see related term pages.

Prenetics Global (Prenetics Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Net Reserve Development From Prior Years (USD Mil)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG

Website

https://www.prenetics.com

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.